Genspera Inc (OTCQB:GNSZ)

0.77
Data as of 2:35pm ET
 -0.025 / -3.14%
Today’s Change
0.73
Today|||52-Week Range
1.80
-40.77%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$25.1M

Company Description

GenSpera, Inc. is a development-stage pharmaceutical company, which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of cancerous tumors, including prostate, brain and other cancers. Its technology platform combines, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that targets the release of the drug only within the tumor. The company was founded by Craig A. Dionne John T. Issacs and Samuel R. Denmeade on November 21, 2003 and is headquartered in San Antonio, TX.

Contact Information

GenSpera, Inc.
2511 North Loop 1604 West
San Antonio Texas 78258
P:(210) 479-8112
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Craig A. DionneChairman, President, CEO, CFO & CAO
Russell B. RichersonChief Operating Officer & Secretary

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.